UC Davis Successfully Treats Cancer in Dog of Olympic Champion and Actor/Singer Star Couple


Hunter, a 9-year-old cocker spaniel, lives a great life with his owners Brian Boitano and Franc D’Ambrosio. But when D’Ambrosio noticed an abnormality while performing a routine anal sac expression, they took Hunter to their veterinarian who diagnosed apocrine gland anal sac adenocarcinoma (AGASACA). While AGASACA represents 17% of all perianal tumors in dogs, it only makes up 2% of all canine skin tumors.

“Assistant Manager” Cat Gets Cancer Treatment and Moves Research Forward


What should a business owner do when a favorite employee gets cancer? What if that employee is a cat? When Horatio, “Assistant Manager Cat” of Seventh Son Brewing Co. in Columbus, Ohio—loved by guests and staff alike—was diagnosed with fibrosarcoma, the brewery took an unconventional approach to help both Horatio and the species. Seventh Son opened a GoFundMe for which 50 percent of the proceeds go to Horatio’s treatment, and the other 50 percent to the UC Davis Feline Cancer Research Fund and an Ohio organization dedicated to saving pets' lives through funding veterinary care.

Philanthropic Fund Helps Dog Beat Cancer

Scruffy, an 11-year-old male Australian shepherd mix, was successfully treated with radiation therapy at the UC Davis veterinary hospital for his nasal mass.

Celebrating A Decade Cancer Free

Tiddles was a 4-year-old Papillon when he was diagnosed in 2011 with a brain tumor. His referring veterinarian gave him approximately 2 months to live. Other documented cases showed that, even with innovative treatments, he would probably not survive more than a year or two. But thanks to research, equipment, and treatments made possible by the donors to the Center for Companion Animal Health, Tiddles beat the odds. He recently turned 15 and is celebrating a decade of being cancer free.

New Clinical Trials Leadership at UC Davis

The Veterinary Center for Clinical Trials at the UC Davis School of Veterinary Medicine welcomes Drs. Krystle Reagan, DVM, PhD, DACVIM (SAIM) and Robert Rebhun, DVM, PhD, DACVIM (Oncology) as new co-directors of the center.